Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase

Abstract

Adriamycin (ADR) is a commonly used chemotherapeutic agent that is believed to exert its effects through the generation of oxygen free radicals. We hypothesized that administration of a single dose of ADR results in endothelial nitric oxide synthase (eNOS)-dependent generation of superoxide (O₂ ^·-) and acute endothelial dysfunction. A single dose of ADR (10 mg/kg i.v.) administered to rabbits resulted in rapid attenuation of agonist-dependent responses to acetylcholine and calcium ionophore (A23187). In vitro exposure of ring segments to ADR for <30 min resulted in O₂ ^·- generation measured by electron spin resonance (ESR) with the spin trap segments 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BMPO) that was abolished by endothelial denudation and incubation with diphenyliodonium (DPI) (10 mM) but not L-NMMA (10 mM). Brachial artery flow-mediated dilation (FMD) in patients undergoing chemotherapy with ADR was markedly attenuated after a single dose of ADR (6.5 6 1.0 to 2.5 6 1.1% (p = 0.0004, time to end of infusion 27 6 8 min) while endothelial-independent dilatation with nitroglycerin was unchanged (16.3 6 3.1 and 14.33 6 2.1% respectively, p = 0.36). Serum nitrite and nitrate concentrations fell from 50 6 6 mmol/l pre-ADR to 33 6 6 mmol/l post-ADR infusion (p = 0.0005) while serum concentrations of CD141 thrombomodulin and von Wille-brand factor (vWF) activity remained unchanged after ADR infusion (36 6 13 to 52 6 22% ng/ml versus 3.25 6 0.98 to 3.01 6 0.91%, respectively, p = NS for pre versus post for both). Doppler indices of diastolic function (IVRT, DT and E/A ratios) were not altered in response to ADR. In conclusion, ADR administration results in rapid depletion of systemic NO^· levels and attenuation of agonist-dependent responses in rabbits and flow-mediated dilation in the brachial artery of humans. ESR measurements in rabbit ring suggest an endothelial origin for radical production via flavin-containing oxido-reductases such as eNOS or NADPH cytochrome P450 reductase. These fi ndings may have implications for cardiovascular complications noted with ADR.

Keywords

adriamycin endothelium nitric oxide superoxide free radicals

References

Bristow MR , Thompson PD , Martin RP , Mason JW , Billingham ME , Harrison DC. Early anthracycline cardiotoxicity. Am J Med 1978; 5: 823-832.

Steinherz LJ , Steinherz PG , Tan CT , Heller G , Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.

Singal PK , Iliskovic N , Li T , Kumar D. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J 1997; 11: 931-936.

Vasquez-Vivar J , Martasek P , Hogg N , Masters BS , Pritchard KA , Kalyanaraman B. Endothelial nitric oxide synthase-dependent super-oxide generation from adriamycin. Biochemistry 1997; 36: 11293-11297.

Kalivendi SV , Kotamraju S , Zhao H , Joseph J , Kalyanaraman B. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic anti-oxidants and calcium. J Biol Chem 2001; 276: 47266-47276.

Rajagopalan S , Kurz S , Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-1923.

Zhao H , Joseph J , Zhang H , Karoui H , Kalyanaraman B. Synthesis and biochemical applications of a solid cyclic nitrone spin trap: a relatively superior trap for detecting superoxide anions and glutathiyl radicals. Free Radic Biol Med 2001; 31: 599-606.

Celermajer DS , Sorensen KE , Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.

Anderson TJ , Uehata A , Gerhard MD et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.

10.

Handa K , Sato S. Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfi te oxidation. Gann 1974; 66: 43-47.

11.

Rajagopalan S , Politi PM , Sinha BK , Myers CE. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 1988; 48: 4766-4769.

12.

Dikalov S , Landmesser U , Harrison DG. Geldanamycin leads to super-oxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of hsp90 and endothelial cell nitric-oxide synthase. J Biol Chem 2002; 277: 25480-25485.

13.

Kaye DM , Jennings G , Angus JA. Evidence for impaired endothelium dependent vasodilation in experimental left ventricular dysfunction. Clin Exp Pharmacol Physiol 1994; 21: 709-719.

14.

Rabkin SW , Ohmae M. Effects of doxorubicin (adriamycin) on systemic hemodynamics and myocardial blood flow. Pharmacology 1982; 25: 272-277.

15.

Kotamraju S , Konorev EA , Joseph J , Kalyanaraman B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 2000; 275: 33585-33592.

16.

Wang HD , Pagano PJ , Du Y et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998; 82: 810-818.

17.

Pagano PJ , Clark JK , Cifuentes-Pagano ME , Clark SM , Callis GM , Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA 1997; 94: 14483-14488.

18.

Griendling KK , Sorescu D , Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.

19.

Greene RF , Collins JM , Jenkins JF , Speyer JL , Myers CE. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res 1983; 43: 3417-3421.

20.

Eksborg S , Strandler HS , Edsmyr F , Naslund I , Tahvanainen P. Pharmacokinetic study of i.v. infusions of adriamycin. Eur J Pharmacol 1985; 28: 205-212.

21.

Huie RE , Padmaja S. The reaction of NO with superoxide. Free Radic Res 1993; 18: 195-199.

22.

Negoro S , Oh H , Tone E et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/akt phosphorylation and bcl-xl/caspase-3 interaction. Circulation 2001; 103: 555-561.

23.

Dimmeler S , Fleming I , Fisslthaler B , Hermann C , Busse R , Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.